Literature DB >> 18285496

Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Shona Wilson1, Frances M Jones, Joseph K Mwatha, Gachuhi Kimani, Mark Booth, H Curtis Kariuki, Birgitte J Vennervald, John H Ouma, Eric Muchiri, David W Dunne.   

Abstract

Hepatosplenomegaly among Kenyan schoolchildren has been shown to be exacerbated where there is transmission of both Schistosoma mansoni and Plasmodium falciparum. This highly prevalent and chronic morbidity often occurs in the absence of ultrasound-detectable periportal fibrosis and may be due to immunological inflammation. For a cohort of school-age children, whole-blood cultures were stimulated with S. mansoni soluble egg antigen (SEA) or soluble worm antigen (SWA). Responses to SWA were found to be predominantly Th2 cytokines; however, they were not significantly associated with either hepatosplenomegaly or infection with S. mansoni or P. falciparum. In comparison, SEA-specific Th2 cytokine responses were low, and the levels were negatively correlated with S. mansoni infection intensities and were lower among children who were coinfected with P. falciparum. Tumor necrosis factor alpha levels in response to stimulation with SEA were high, and a negative association between presentation with hepatomegaly and the levels of the regulatory cytokines interleukin-6 and transforming growth factor beta(1) suggests that a possible mechanism for childhood hepatomegaly in areas where both malaria and schistosomiasis are endemic is poor regulation of an inflammatory response to schistosome eggs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285496      PMCID: PMC2346678          DOI: 10.1128/IAI.01433-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Immunology of hepatosplenic schistosomiasis mansoni: a human perspective.

Authors:  D W Dunne; E J Pearce
Journal:  Microbes Infect       Date:  1999-06       Impact factor: 2.700

2.  Role of IL-6 in directing the initial immune response to schistosome eggs.

Authors:  A C La Flamme; A S MacDonald; E J Pearce
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 3.  The immunobiology of schistosomiasis.

Authors:  Edward J Pearce; Andrew S MacDonald
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

4.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

5.  Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.

Authors:  Claus M Reimert; Colin M Fitzsimmons; Sarah Joseph; Joseph K Mwatha; Frances M Jones; Gachuhi Kimani; Karl F Hoffmann; Mark Booth; Narcis B Kabatereine; David W Dunne; Birgitte J Vennervald
Journal:  Clin Vaccine Immunol       Date:  2006-05

6.  Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity.

Authors:  P Boisier; C E Ramarokoto; P Ravoniarimbinina; L Rabarijaona; V E Ravaoalimalala
Journal:  Trop Med Int Health       Date:  2001-09       Impact factor: 2.622

7.  Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice.

Authors:  A Yoshida; H Maruyama; T Kumagai; T Amano; F Kobayashi; M Zhang; K Himeno; N Ohta
Journal:  Int Immunol       Date:  2000-08       Impact factor: 4.823

8.  Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.

Authors:  Joseph K Mwatha; Frances M Jones; Gamal Mohamed; Cynthia W A Naus; Eleanor M Riley; Anthony E Butterworth; Gachuhi Kimani; Curtis H Kariuki; John H Ouma; Davy Koech; David W Dunne
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

9.  Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence.

Authors:  M Booth; B J Vennervald; N B Kabatereine; F Kazibwe; J H Ouma; C H Kariuki; E Muchiri; H Kadzo; E Ireri; G Kimani; J K Mwatha; D W Dunne
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-02       Impact factor: 2.184

10.  IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.

Authors:  Samson M Kinyanjui; David J Conway; David E Lanar; Kevin Marsh
Journal:  Malar J       Date:  2007-06-28       Impact factor: 2.979

View more
  20 in total

1.  Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.

Authors:  Takafira Mduluza; Francisca Mutapi; Tinashe Ruwona; Daniel Kaluka; Nicholas Midzi; Patricia D Ndhlovu
Journal:  Malawi Med J       Date:  2009-12       Impact factor: 0.875

2.  Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

Authors:  Erick M O Muok; Erick M O Mouk; Pauline N M Mwinzi; Carla L Black; Jennifer M Carter; Zipporah W Ng'ang'a; Michael M Gicheru; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

Review 3.  Th2 responses in schistosomiasis.

Authors:  Keke Fairfax; Marcia Nascimento; Stanley Ching-Cheng Huang; Bart Everts; Edward J Pearce
Journal:  Semin Immunopathol       Date:  2012-11-09       Impact factor: 9.623

4.  Experimental murine fascioliasis derives early immune suppression with increased levels of TGF-β and IL-4.

Authors:  Joon-Yong Chung; Young-An Bae; Doo-Hee Yun; Hyun-Jong Yang; Yoon Kong
Journal:  Korean J Parasitol       Date:  2012-11-26       Impact factor: 1.341

5.  Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria.

Authors:  Natsuko Imai; Nadine Rujeni; Norman Nausch; Claire D Bourke; Laura J Appleby; Graeme Cowan; Reggis Gwisai; Nicholas Midzi; David Cavanagh; Takafira Mduluza; David Taylor; Francisca Mutapi
Journal:  Parasitology       Date:  2011-08-04       Impact factor: 3.234

Review 6.  Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.

Authors:  Shona Wilson; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30

Review 7.  Acquired immune heterogeneity and its sources in human helminth infection.

Authors:  C D Bourke; R M Maizels; F Mutapi
Journal:  Parasitology       Date:  2010-10-15       Impact factor: 3.234

8.  Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni.

Authors:  Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-10-08       Impact factor: 2.184

9.  Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children.

Authors:  Lia S Florey; Charles H King; Melissa K Van Dyke; Eric M Muchiri; Peter L Mungai; Peter A Zimmerman; Mark L Wilson
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

10.  Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.

Authors:  Claire D Bourke; Norman Nausch; Nadine Rujeni; Laura J Appleby; Kate M Mitchell; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.